Search research articles
Contact Us
Filters
Showing results (151-160 of 171) with videos related to
Page
of 18
Sort By:
Progress in Clinical and Biological Research
|
January 1, 1994
Receptor-mediated toxicity and implications for risk assessment
M E Andersen, J J Mills, T R Fox, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
February 1, 1993
Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment
M E Andersen, J J Mills, M L Gargas, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
March 15, 2001
The effect of pregnancy on renal clearance of boron in rats given boric acid orally
N D Vaziri, F Oveisi, B D Culver, et al.
Chemico-Biological Interactions
|
June 1, 1996
A pharmacokinetic model of anaerobic in vitro carbon tetrachloride metabolism
N J Andersen, C L Waller, J B Adamovic, et al.
Toxicology and Applied Pharmacology
|
March 15, 1991
Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans
M E Andersen, H J Clewell, M L Gargas, et al.
British Journal of Obstetrics and Gynaecology
|
September 1, 1988
Bacterial vaginosis: a double-blind randomized trial of the effect of treatment of the sexual partner
M Vejtorp, A C Bollerup, L Vejtorp, et al.
Inhalation Toxicology
|
September 9, 2020
Response to "letter concerning: Clewell (2019) incorporation of <i>in vitro</i> metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene." (UIHT-2020-0053)
H J Clewell, J L Campbell, C Van Landingham, et al.
Environmental Health Perspectives
|
July 28, 1999
Quantitative mechanistically based dose-response modeling with endocrine-active compounds
M E Andersen, R B Conolly, E M Faustman, et al.
Cancer Research
|
March 31, 2001
A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay
Y C Ou, R B Conolly, R S Thomas, et al.
Toxicology and Applied Pharmacology
|
September 15, 1990
Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling
R H Reitz, A L Mendrala, R A Corley, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 171) with videos related to
Sort By:
Page
of 18
Progress in Clinical and Biological Research
|
January 1, 1994
Receptor-mediated toxicity and implications for risk assessment
M E Andersen, J J Mills, T R Fox, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
February 1, 1993
Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment
M E Andersen, J J Mills, M L Gargas, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
March 15, 2001
The effect of pregnancy on renal clearance of boron in rats given boric acid orally
N D Vaziri, F Oveisi, B D Culver, et al.
Chemico-Biological Interactions
|
June 1, 1996
A pharmacokinetic model of anaerobic in vitro carbon tetrachloride metabolism
N J Andersen, C L Waller, J B Adamovic, et al.
Toxicology and Applied Pharmacology
|
March 15, 1991
Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans
M E Andersen, H J Clewell, M L Gargas, et al.
British Journal of Obstetrics and Gynaecology
|
September 1, 1988
Bacterial vaginosis: a double-blind randomized trial of the effect of treatment of the sexual partner
M Vejtorp, A C Bollerup, L Vejtorp, et al.
Inhalation Toxicology
|
September 9, 2020
Response to "letter concerning: Clewell (2019) incorporation of <i>in vitro</i> metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene." (UIHT-2020-0053)
H J Clewell, J L Campbell, C Van Landingham, et al.
Environmental Health Perspectives
|
July 28, 1999
Quantitative mechanistically based dose-response modeling with endocrine-active compounds
M E Andersen, R B Conolly, E M Faustman, et al.
Cancer Research
|
March 31, 2001
A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay
Y C Ou, R B Conolly, R S Thomas, et al.
Toxicology and Applied Pharmacology
|
September 15, 1990
Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling
R H Reitz, A L Mendrala, R A Corley, et al.
Page
of 18